Experienced in Disseminated Tuberculosis

Gompol Suwanpimolkul

Bangkok, TH 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Disseminated Tuberculosis
Bangkok, TH 
OverviewLocationsClinical Research

Overview

Gompol Suwanpimolkul practices in Bangkok, Thailand. Suwanpimolkul is rated as an Experienced expert by MediFind in the treatment of Disseminated Tuberculosis. Their top areas of expertise are Disseminated Tuberculosis, Pulmonary Tuberculosis, SVC Obstruction, and HIV/AIDS.

Their clinical research consists of co-authoring 37 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Disseminated Tuberculosis.

Locations

Bangkok, 10330, Thailand
Other Locations
Thai Red Cross, Thailand

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Efficacy, Safety and Pharmacokinetics of Dolutegravir 50 Mg Once Daily with Food Versus Dolutegravir 50 Mg Twice Daily in HIV/TB Co-infected Patients Receiving Rifampin-based Antituberculosis Therapy
Efficacy, Safety and Pharmacokinetics of Dolutegravir 50 Mg Once Daily with Food Versus Dolutegravir 50 Mg Twice Daily in HIV/TB Co-infected Patients Receiving Rifampin-based Antituberculosis Therapy
Enrollment Status: Recruiting
Publish Date: October 02, 2024
Intervention Type: Drug
Study Drug: Dolutegravir
Study Phase: Phase 2
Improve Treatment Outcomes for Tuberculosis Infection in Tertiary Care Hospitals
Improve Treatment Outcomes for Tuberculosis Infection in Tertiary Care Hospitals
Enrollment Status: Active_not_recruiting
Publish Date: March 17, 2025
Intervention Type: Diagnostic test
Study Phase: Not Applicable
A Pilot Study of the Pharmacokinetics and Safety of Rifabutin 150 mg Once Daily Versus Rifabutin 300 mg Thrice Weekly With Lopinavir/Ritonavir Based HAART in HIV/TB Co-infected Patients
A Pilot Study of the Pharmacokinetics and Safety of Rifabutin 150 mg Once Daily Versus Rifabutin 300 mg Thrice Weekly With Lopinavir/Ritonavir Based HAART in HIV/TB Co-infected Patients
Enrollment Status: Completed
Publish Date: February 12, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trial

37 Total Publications

NAT2 polymorphisms and Antituberculosis-Induced Hepatotoxicity in Thai People Living with HIV: Insights from a Pharmacogenetic-Pharmacokinetic Cohort Study.
NAT2 polymorphisms and Antituberculosis-Induced Hepatotoxicity in Thai People Living with HIV: Insights from a Pharmacogenetic-Pharmacokinetic Cohort Study.
Journal: The Journal of infectious diseases
Published: July 24, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Suwanpimolkul's expertise for a condition
ConditionClose
        View All 11 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile